1.
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
by Fufaa, Gudeta D
Diabetologia, 2014-10-15, Vol.58 (1), p.188-198

2.
Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
by Fabiano, Rafaela Cabral Gonçalves
Pediatric nephrology (Berlin, West), 2017-02-23, Vol.32 (7), p.1211-1220

3.
Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents
by Kim, Siah
Pediatric nephrology (Berlin, West), 2016-06-23, Vol.32 (1), p.119-129

4.
Common clinical markers predict end-stage renal disease in children with obstructive uropathy
by McLeod, Daryl J
Pediatric nephrology (Berlin, West), 2018-10-13, Vol.34 (3), p.443-448

5.
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
by Roscioni, S. S
Diabetologia, 2013-02, Vol.56 (2), p.259-267

6.
Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury
by Westhoff, Jens H
European journal of pediatrics, 2017-04-14, Vol.176 (6), p.745-755

7.
Another atypical case of acute kidney injury—or not? Answers
by Keenswijk, Werner
Pediatric nephrology (Berlin, West), 2016-12-02, Vol.32 (10), p.1881-1883

8.
Prospective analysis of long-term renal function in survivors of childhood Wilms tumor
by Neu, Marie A
Pediatric nephrology (Berlin, West), 2017-04-28, Vol.32 (10), p.1915-1925

9.
Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
by Agrawal, Lily
Diabetologia, 2017-11-03, Vol.61 (2), p.295-299

10.
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes
by Hadjadj, Samy
Diabetologia, 2015-10-20, Vol.59 (1), p.208-216

11.
Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension
by Lou-Meda, Randall
Pediatric nephrology (Berlin, West), 2018-11-05, Vol.34 (3), p.495-506

12.
Longitudinal patterns of urine biomarkers in infants across gestational ages
by DeFreitas, Marissa J
Pediatric nephrology (Berlin, West), 2016-02-09, Vol.31 (7), p.1179-1188

13.
Treatment of hyperphosphatemia: the dangers of high PTH levels
by Bacchetta, Justine
Pediatric nephrology (Berlin, West), 2019-11-06, Vol.35 (3), p.493-500

14.
Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases
by Vianna, Heloisa Reniers
Pediatric nephrology (Berlin, West), 2012-11-18, Vol.28 (3), p.463-469

15.
Retinal and choroidal vasculature changes associated with chronic kidney disease
by Vadalà, Maria
Graefe's archive for clinical and experimental ophthalmology, 2019-05-30, Vol.257 (8), p.1687-1698

16.
Prevalence of risk factors for chronic kidney disease in South African youth with perinatally acquired HIV
by Frigati, Lisa
Pediatric nephrology (Berlin, West), 2018-09-15, Vol.34 (2), p.313-318

17.
Estimating glomerular filtration rate in children: evaluation of creatinine- and cystatin C-based equations
by Salvador, Cathrin L
Pediatric nephrology (Berlin, West), 2018-08-31, Vol.34 (2), p.301-311

18.
Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study
by Nanayakkara, Shanika
Environmental health and preventive medicine, 2012-03, Vol.17 (2), p.109-117

19.
Emerging biomarkers of chronic kidney disease in children
by Greenberg, Jason H
Pediatric nephrology (Berlin, West), 2017-06-17, Vol.33 (6), p.925-933

20.
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia
by Lebensburger, Jeffrey D
Pediatric nephrology (Berlin, West), 2017-04-05, Vol.32 (9), p.1565-1573
